Founded in 1991, the CDMO Division of Lubrizol Life Science Health (LLS Health) has established itself as a leading contract development and manufacturing organization. Staffed by experienced CDMO industry experts, we offer drug product formulation and a comprehensive suite of supporting services including analytic, bioanalytic, physical characterization and manufacturing. A variety of technologies and the ability to deal with poorly soluble and highly potent compounds under GxPs in both sterile and non-sterile environments distinguishes us from others.
Our goal is to become a true CDMO partner by designing and producing the most effective drug products for our clients. From the beginning, we have been leading the way with commercial innovations, scaling our first nano-particle back in 1994. Today our clients include over half of the leading pharmaceutical and biotech companies, governments, foundations, universities, hospitals and privately-backed start-ups.
Route of Delivery
Oral and Other